RecruitingPhase 1NCT06565195
A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
Sponsor: Prevail Therapeutics
New Haven, CT · +6 more sites
Parkinson's Disease clinical trials in New Haven, CT
18 recruiting parkinson's disease studies with a site in New Haven, CT.
All trials in New Haven, CT · All Parkinson's Disease trials
RecruitingPhase 3NCT06623422
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Sponsor: Merck Sharp & Dohme LLC
New Haven, CT · Norwich, CT · +52 more sites
RecruitingPhase 3NCT06312176
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Sponsor: Merck Sharp & Dohme LLC
New Haven, CT · Stamford, CT · +44 more sites
RecruitingPhase 3NCT06841354
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Sponsor: Merck Sharp & Dohme LLC
New Haven, CT · +38 more sites
RecruitingPhase 3NCT06952504
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Sponsor: Merck Sharp & Dohme LLC
New Haven, CT · +52 more sites
RecruitingPhase 3NCT07174310
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Sponsor: Hoffmann-La Roche
New Haven, CT · +52 more sites
RecruitingPhase 2 / Phase 3NCT06976268
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Sponsor: Biohaven Therapeutics Ltd.
Farmington, CT · New Haven, CT · +22 more sites
RecruitingPhase 2NCT07610369
The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
Sponsor: Yale University
New Haven, CT
RecruitingPhase 2NCT07830654
This Protocol is a Sub-study Under the PPMI Program. It is a Longitudinal, Single-center Study to Assess the Performance of [18F]AV-133 Imaging Using High and Standard Resolution PET in Individuals Enrolled With Parkinson's Disease (PD) for up to 12 Months.
Sponsor: Michael J. Fox Foundation for Parkinson's Research
New Haven, CT
RecruitingPhase 2NCT07809438
A Comparative Performance Study Between High and Standard Resolution Positron Emission Tomography Camera Using [18F] AV-133 in Prodromal Parkinson's Disease
Sponsor: Michael J. Fox Foundation for Parkinson's Research
New Haven, CT
RecruitingPhase not listedNCT07330258
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
Sponsor: Bayer
New Haven, CT · +26 more sites
RecruitingPhase 2NCT07020026
Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease
Sponsor: Michael J. Fox Foundation for Parkinson's Research
New Haven, CT
RecruitingPhase not listedNCT04477785
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Sponsor: Michael J. Fox Foundation for Parkinson's Research
New Haven, CT · +29 more sites
RecruitingEarly Phase 1NCT07640555
Evaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies
Sponsor: MODAG GmbH
New Haven, CT
RecruitingEarly Phase 1NCT07617688
Evaluation of the Pharmacokinetics, Biodistribution and Radiation Dosimetry of [18F]MODAG-009 Positron Emission Tomography (PET) Radiotracers in Adult Healthy Volunteers
Sponsor: MODAG GmbH
New Haven, CT
RecruitingEarly Phase 1NCT06303921
Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503
Sponsor: University of Pennsylvania
New Haven, CT · +2 more sites
RecruitingPhase 2NCT06402955
Imaging Depression in Parkinson's Disease
Sponsor: Yale University
New Haven, CT
RecruitingPhase 2NCT07265596
Early Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging)
Sponsor: Michael J. Fox Foundation for Parkinson's Research
New Haven, CT · +1 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.